Verified Panel · Accessibility-First · Burden Studies
Research built for a sense central to independence
Rare ophthalmological conditions affect a sense central to independence, employment, education, and social connection — and research design in this category must account for vision-related accessibility needs within the research process itself, not only as a study topic.
MedPanel applies verified panel recruitment and accessibility-first methodology to support sponsors researching rare and inherited eye diseases across the full evidence lifecycle.
Functional vision · Onset · Accessibility
N. America · Europe · Asia-Pacific · LATAM
Physician attestation · Medical record
Screen-reader · Audio-described · Flexible
Why This Therapeutic Area Requires Distinct Research Design
Three characteristics of rare eye disease shape how research in this area must be designed — including the accessibility of the research process itself.
- Functional vision impact extends beyond acuity. It encompasses mobility, reading ability, facial recognition, driving capacity, and employment implications that vary considerably depending on the specific pattern of vision loss involved — central versus peripheral, progressive versus stable, and the age at which vision loss began. Generic vision-related quality-of-life instruments frequently fail to capture this functional nuance.
- Progressive versus congenital onset is a critical distinction. Patients who lose vision progressively as adults experience a fundamentally different psychological and practical adaptation process than those with congenital or early-childhood onset vision impairment, and research design should account for this distinction rather than treating all patients with a given diagnosis as having comparable lived experience.
- Accessibility of the research process itself is a design requirement. Standard digital survey interfaces, visual stimulus materials, and even video-based focus group formats may present participation barriers that research teams must proactively address.
Research Approaches MedPanel Applies in This Therapeutic Area
MedPanel matches methodology to the specific research question, drawing on functional-impact, treatment-experience, caregiver, and genetic-counseling research designs.
Functional impact and burden-of-illness research
Functional impact and burden-of-illness research in this category is designed around the specific vision loss pattern relevant to the condition under study, capturing mobility, independence, employment, and social participation dimensions with appropriate granularity. MedPanel’s burden studies methodology incorporates condition-specific functional impact assessment rather than relying on acuity measures alone.
Treatment experience and emerging therapy research
Treatment experience and emerging therapy research, including patient and family perspective on gene therapy and other novel modalities entering this category, draws on MedPanel’s focus group and in-depth interview methodologies, both adapted for accessible delivery to participants with significant vision impairment.
Caregiver and family research
Caregiver and family research is particularly relevant for congenital and pediatric-onset conditions, where parents manage early intervention, educational accommodation, and long-term independence planning. MedPanel’s caregiver studies practice extends to this population with appropriate framework adaptation.
Diagnostic and genetic counseling experience research
Diagnostic and genetic counseling experience research supports sponsors developing therapies for inherited retinal and other genetic eye conditions, capturing how patients and families navigate genetic testing, diagnosis communication, and family planning considerations relevant to hereditary conditions in this category.
Accessible Research Design as Standard Practice
Accessibility is built into every stage of the research process for this therapeutic area — not added as a custom accommodation requested case by case.
MedPanel builds accessibility into every stage of the research process for this therapeutic area — screen reader–compatible survey instruments, audio-described or verbally narrated stimulus materials where visual materials are part of the study design, and flexible session formats for focus groups and interviews that accommodate participants who may rely on assistive technology or a support person during the session. These are standard features of MedPanel’s approach to this therapeutic area, not custom accommodations requested case by case.
A Verified Panel for a Clinically Specific Population
Inherited and rare eye diseases frequently involve precise genetic or clinical subtyping, making recruitment precision essential.
Inherited and rare eye diseases frequently involve precise genetic or clinical subtyping that affects both prognosis and treatment eligibility, making recruitment precision essential. MedPanel’s verification protocol — physician attestation and medical record confirmation rather than self-report — ensures recruited participants match the specific diagnostic criteria a study requires.
MedPanel’s global reach across North America, Europe, Asia-Pacific, and Latin America supports research across markets with differing access to genetic testing and specialist ophthalmology care relevant to rare and inherited eye conditions.
Start your research
Start Your Rare Ophthalmological Condition Research Program
From accessible functional impact research to genetic counseling experience studies, MedPanel’s verified panel and rare disease specialists bring the accessibility-first design this population requires.
Panel feasibility confirmed for your target population
Methodology recommended for your study goals
Accessibility-first design built in as standard
Verified recruitment — physician attestation & medical record
Contact MedPanel to discuss your research objectives in rare ophthalmological conditions. We will confirm panel feasibility and recommend a methodology suited to your study goals.